5-115986122-T-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_173800.5(LVRN):c.978+1413T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.413 in 152,148 control chromosomes in the GnomAD database, including 14,558 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.41 ( 14558 hom., cov: 34)
Consequence
LVRN
NM_173800.5 intron
NM_173800.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -2.21
Publications
8 publications found
Genes affected
LVRN (HGNC:26904): (laeverin) Predicted to enable metalloaminopeptidase activity; peptide binding activity; and zinc ion binding activity. Predicted to be involved in several processes, including peptide catabolic process; proteolysis; and regulation of blood pressure. Predicted to be integral component of membrane. Predicted to be active in cytoplasm and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.866 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| LVRN | NM_173800.5 | c.978+1413T>G | intron_variant | Intron 3 of 19 | ENST00000357872.9 | NP_776161.3 | ||
| LVRN | XM_047416913.1 | c.285+1413T>G | intron_variant | Intron 3 of 19 | XP_047272869.1 | |||
| LVRN | XM_047416914.1 | c.189+1413T>G | intron_variant | Intron 3 of 19 | XP_047272870.1 | |||
| LVRN | XM_047416915.1 | c.189+1413T>G | intron_variant | Intron 3 of 19 | XP_047272871.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.413 AC: 62803AN: 152030Hom.: 14535 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
62803
AN:
152030
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.413 AC: 62868AN: 152148Hom.: 14558 Cov.: 34 AF XY: 0.418 AC XY: 31116AN XY: 74390 show subpopulations
GnomAD4 genome
AF:
AC:
62868
AN:
152148
Hom.:
Cov.:
34
AF XY:
AC XY:
31116
AN XY:
74390
show subpopulations
African (AFR)
AF:
AC:
21618
AN:
41488
American (AMR)
AF:
AC:
7539
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
AC:
1366
AN:
3472
East Asian (EAS)
AF:
AC:
4598
AN:
5182
South Asian (SAS)
AF:
AC:
2688
AN:
4820
European-Finnish (FIN)
AF:
AC:
2599
AN:
10600
Middle Eastern (MID)
AF:
AC:
104
AN:
294
European-Non Finnish (NFE)
AF:
AC:
21263
AN:
67992
Other (OTH)
AF:
AC:
908
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1818
3636
5453
7271
9089
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
586
1172
1758
2344
2930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2473
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.